Meredith Cook
Consigliere Generale presso ANI PHARMACEUTICALS, INC.
Patrimonio netto: 4 M $ in data 30/04/2024
Posizioni attive di Meredith Cook
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ANI PHARMACEUTICALS, INC. | Consigliere Generale | 18/07/2022 | - |
| Segretario Aziendale | 18/07/2022 | - |
Storia della carriera di Meredith Cook
Precedenti posizioni note di Meredith Cook
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Amneal Intermediate, Inc.
 Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | - | - |
Formazione di Meredith Cook
| Princeton University | Undergraduate Degree |
| Tulane University Law School | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| General Counsel | 1 |
| Corporate Secretary | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ANI PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | Health Technology |
- Borsa valori
- Insiders
- Meredith Cook
- Esperienza
